Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01453153 |
|
Recruitment Status
:
Completed
First Posted
: October 17, 2011
Last Update Posted
: February 26, 2018
|
Sponsor:
Halozyme Therapeutics
Information provided by (Responsible Party):
Halozyme Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2014 |
| Actual Study Completion Date : | May 2015 |
| Certification/Extension First Submitted : | February 22, 2018 |